Rain Oncology to be acquired by Pathos AI for $1.16 in cash per share (NASDAQ:RAIN)
cagkansayin/iStock via Getty Images Rain Oncology (NASDAQ:RAIN) has agreed to be acquired by Pathos AI for $1.16, per share in cash and a potential cash payments of up to approximately $0.17 per share. Based in Newark, California the…